Healthcare -
Biotechnology - NASDAQ - US
$ 9.02
2.85 %
$ 446 M
Market Cap
-2.45
P/E
KALV - ACCOUNTS PAYABLE
Accounts Payable KALV - KalVista Pharmaceuticals, Inc.
9.11 M
LAST VALUE
58.22%
2 YEAR CAGR
26.07%
5 YEAR CAGR
34.73%
10 YEAR CAGR